172 related articles for article (PubMed ID: 2335397)
21. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
[TBL] [Abstract][Full Text] [Related]
22. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
[TBL] [Abstract][Full Text] [Related]
23. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238
[TBL] [Abstract][Full Text] [Related]
24. [Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):379-85. PubMed ID: 2930203
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
26. Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers.
Furukawa T; Kumai K; Kubota T; Hirahata S; Shimizu H; Matsui H; Takahara T; Aizawa K; Shibata S; Shimada A
Surg Today; 1993; 23(4):298-306. PubMed ID: 8318783
[TBL] [Abstract][Full Text] [Related]
27. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
[TBL] [Abstract][Full Text] [Related]
28. 'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.
Abe R; Akiyoshi T; Baba T
Oncology; 1990; 47(5):422-6. PubMed ID: 2216298
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
30. ["Two route infusion chemotherapy" of cis-diamminedichloro-platinum (II) and its antidote, sodium thiosulfate, for rat bladder tumor (author's transl)].
Sagiyama K; Uozumi J; Baba T
Nihon Hinyokika Gakkai Zasshi; 1982 Mar; 73(3):287-93. PubMed ID: 7202077
[No Abstract] [Full Text] [Related]
31. Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice.
Kyriazis AP; Yagoda A; Kereiakes JG; Kyriazis AA; Whitmore WF
Cancer; 1983 Aug; 52(3):452-7. PubMed ID: 6683120
[TBL] [Abstract][Full Text] [Related]
32. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
Berry JP; Pauwells C; Tlouzeau S; Lespinats G
Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
[TBL] [Abstract][Full Text] [Related]
33. [The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
Takizawa K; Harada M; Fujimaru J; Matsushiro N; Shima Y; Andoh I; Satoh M; Yokoo I; Iguchi T; Hirabayashi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):595-602. PubMed ID: 1619320
[TBL] [Abstract][Full Text] [Related]
34. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
35. Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate.
Abe R; Akiyoshi T; Tsuji H; Baba T
Cancer Chemother Pharmacol; 1986; 18(2):98-100. PubMed ID: 3791566
[TBL] [Abstract][Full Text] [Related]
36. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
[TBL] [Abstract][Full Text] [Related]
37. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
38. [Intraarterial DDP and angiotensin II infusion chemotherapy].
Mitsuhata N; Matsumura Y
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1429-38. PubMed ID: 3015032
[TBL] [Abstract][Full Text] [Related]
39. Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.
Uozumi J; Ishizawa M; Iwamoto Y; Baba T
Cancer Chemother Pharmacol; 1984; 13(2):82-5. PubMed ID: 6540631
[TBL] [Abstract][Full Text] [Related]
40. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
